Brief: Gen Ilac Signs Representative And Service Agreement For Mrna-1273 Vaccine With Moderna Switzerland GMBH
16/05/2022 13:16
May 16 (Reuters) - GEN ILAC GENIL.IS :
* SIGNS REPRESENTATIVE AND SERVICE AGREEMENT FOR MRNA-1273
VACCINE
WITH MODERNA SWITZERLAND GMBH ON 13TH OF MAY
* COMPANY WILL HELP MODERNA IN PROVIDING BUSINESS
OPPORTUNITIES
FOR POTENTIAL SUPPLY OF VACCINE IN TURKEY
Source text for Eikon: urn:newsml:reuters.com:*:nIKA422xzM
Further company coverage: GENIL.IS
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Gen Ilac ve Saglik Urunleri Sanayi Ticaret
See all newsBrief: Gen Ilac Says It Wins Pharmaceutical Tender In Kazakhstan, Expects $1.19 Million Sales Contribution In 2027
Brief: Gen Ilac Says It Participates In Kazakhstan Drug Procurement Tender Via Med Service Plus Authorized By Kazakhstan Representative Office Of Gen Ilac
Brief: Gen Ilac Says It Signs Supply And Distribution Agreement With Incyte On Oct 9
Brief: Gen Ilac Says It Completes Pharmaceutical Manufacturing Plant Investment In Azerbaijan
Brief: Gen Ilac Says It Is To Start Share Buyback Programme For Max 125 Mln Nominal Shares With Allocated Funds Of 1.5 Bln Lira